Clinical Trial Update: Title of Manuscript: Development and Internal-external Validation of a Comprehensive Model for Predicting Risk of Post-RFA Recurrence in HCC Patients

View source ↗

Summary

A clinical study aims to develop and validate a model to predict post-RFA recurrence in hepatocellular carcinoma patients. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Tian'an Jiang | Conditions: Hepatocellular Carcinoma | Status: RECRUITING